Counselors in Lorain, OH Accepting Medicare
224 Counselors found. Showing 161 - 180
 Mrs. Jessica Karen Zemanek, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 6140 S Broadway, Lorain, OH 44053 Phone: 440-233-7232 Fax: 440-204-4315 |
Emily Markel, CDCA Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 2115 W Park Dr, Lorain, OH 44053 Phone: 440-989-4900 |
Mrs. Cynthia M Simo, PCC-S Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 2173 N Ridge Rd E, Lorain, OH 44055 Phone: 440-260-6108 Fax: 440-282-3400 |
Halle M Branscum, CT Counselor Medicare: Not Enrolled in Medicare Practice Location: 6150 Park Square Dr Ste B, Lorain, OH 44053 Phone: 440-984-3882 |
 Mr. Jimmy Jay Christian, CDCA Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 6150 Park Square Dr Ste B, Lorain, OH 44053 Phone: 440-984-3882 |
Migdalia Quinones, CDCA Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 2115 W Park Dr, Lorain, OH 44053 Phone: 440-989-4987 Fax: 440-282-4779 |
Melani A Richards, SOCIAL WORKER Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 6140 South Broadway Ave, Lorain, OH 44053 Phone: 440-204-4364 Fax: 440-233-7232 |
Michael Safranek, CDCA Counselor Medicare: Not Enrolled in Medicare Practice Location: 2115 W Park Dr, Lorain, OH 44053 Phone: 440-989-4900 |
Jamica Clifford Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1882 E 32nd St, Lorain, OH 44055 Phone: 440-989-4968 |
Dacia Fumich, CDCA Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 2115 W Park Dr, Lorain, OH 44053 Phone: 440-989-4900 Fax: 440-282-4779 |
Renee Murfield, CDCA, LCDCII Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 2115 W Park Dr, Lorain, OH 44053 Phone: 440-989-4900 |
Lisa M Brown, LPCC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 6140 S Broadway, Lorain, OH 44053 Phone: 440-233-7232 |
Angela Thompson, LCDCIII.161378 Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 2115 W Park Dr, Lorain, OH 44053 Phone: 440-989-4987 Fax: 440-246-0189 |
Andrea L Jones, LICDC, SAP, ICADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 2115 W Park Dr, Lorain, OH 44053 Phone: 440-989-4987 Fax: 440-246-0189 |
Ms. Savannah Rose Sheets, LPCC Counselor - Professional Medicare: Medicare Enrolled Practice Location: 6140 S Broadway, Lorain, OH 44053 Phone: 440-204-4110 |
Kristiana Dehaan-nuby Counselor Medicare: Not Enrolled in Medicare Practice Location: 2173 N Ridge Rd E Ste E&g, Lorain, OH 44055 Phone: 440-260-6835 |
Jeffrey Rhoads, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 6140 S Broadway, Lorain, OH 44053 Phone: 440-233-7232 Fax: 440-233-9070 |
Sheri Neumann Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 2173 N Ridge Rd E Ste E&g, Lorain, OH 44055 Phone: 440-260-6835 |
Lyn Bruno, CDCA Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 2115 W Park Dr, Lorain, OH 44053 Phone: 440-989-4900 |
Nicole Meil, CDCA Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 2115 W Park Dr, Lorain, OH 44053 Phone: 440-989-4987 Fax: 440-246-0189 |
News Archive
Qioptiq launches 1.73x Tube Lens to optimize mag.x system 125 for 35mm camera format sensors
Qioptiq, an Excelitas Technologies® Company and global technology leader focused on delivering innovative optical and photonic solutions, introduces the new 1.73x Tube Lens as a widely desired addition to the mag.x system 125.
Cytochroma reports positive results from Phase I trial for CTAP201 Injection in hemodialysis patients
Cytochroma today announced positive Phase I results for CTAP201 Injection, a product being developed to treat secondary hyperparathyroidism in hemodialysis patients. The study demonstrated that single intravenous doses of 1 and 3 mcg of CTAP201 were safe and well tolerated. It also identified a starting dose of 2 mcg for subsequent pivotal trials intended to establish the product's safety and efficacy in the targeted population.
New official clinical practice guidelines on diagnosis, management of EIB
The American Thoracic Society has released new official clinical practice guidelines on the diagnosis and management of exercise-induced bronchoconstriction, the acute airway narrowing that occurs as a result of exercise.
Engineers develop free mobile phone app for monitoring glucose levels in diabetic patients
A computer vision technology developed by University of Cambridge engineers has now been developed into a free mobile phone app for regular monitoring of glucose levels in people with diabetes.
Study finds IAP enzyme maintains normal microbial population in gastrointestinal system
An enzyme that keeps intestinal bacteria out of the bloodstream may also play an important role in maintaining the normal microbial population of the gastrointestinal system.
› Verified 1 days ago
Counselors
Clinical Social Workers
Pharmacists
Dentists
Psychologists
Occupational Therapists